Testosterone Gel: An Honest Look at AndroGel, Side Effects, Transfer Risk, and Whether It Beats Injections

Testosterone gel is a topical TRT delivering about 10% of the dose you rub on your shoulders into your bloodstream over 24 hours. AndroGel, Testim, Fortesta, and Natesto are FDA-approved for hypogonadism, cost $300 to $600 monthly without insurance, and fail to reach therapeutic levels in 30 to 50% of men due to absorption variability.

That last number is the one your prescriber probably did not lead with. Gels are sold as the gentle, needle-free entry point to TRT, but they are also the modality with the highest non-responder rate, an FDA black-box warning for transfer to family members, and a 2-hour shower restriction that quietly reshapes your morning. This guide covers what gels actually are, how the brands differ, the dose math, the real cost, the absorption lottery, the transfer risk, and whether gel beats injections for the kind of person you actually are.

What Is Testosterone Gel and How Does It Work?

Testosterone gel is an alcohol-based topical formulation containing 1% to 2% bioidentical testosterone that you apply once daily to clean, dry skin on the shoulders or upper arms. The alcohol base evaporates within minutes, leaving testosterone deposited in the stratum corneum, where it diffuses through the skin into the bloodstream over the next 24 hours. About 10% of the applied dose is absorbed.

The mechanism is transdermal passive diffusion. Once testosterone crosses the lipid layer of the skin and enters circulation, it produces relatively steady-state blood levels within 7 to 14 days of consistent daily dosing. Unlike weekly cypionate injections, which produce a peak 24 to 48 hours after each shot followed by a gradual decline, gels theoretically hold serum testosterone in a narrow daily band.

Theoretically. In practice, blood levels swing meaningfully day-to-day based on application site, sweat, hydration, post-application shower timing, body composition, and a long list of patient-specific variables. The smooth pharmacokinetic curve in the prescribing label is the average. Your daily reality may not match it.

Brand names include AndroGel (1% packets, 1.62% pump), Testim (1% tubes), Fortesta (2% pump), Vogelxo (1% pump or packets), and the intranasal Natesto (4.5% nasal gel applied three times daily). The active ingredient is the same in every product. The vehicle, dose strength, application site, and absorption profile are not.

Did You Know? The FDA approved AndroGel in 2000, making it the first transdermal testosterone gel sold in the U.S. and the product that effectively created the modern TRT-by-mail market.

How Do You Apply Testosterone Gel?

Testosterone gel is applied once daily, ideally in the morning, to clean, dry, intact skin on the shoulders and upper arms. Squeeze or pump the dose into your palm, spread it in a thin layer over both shoulders and the outer upper arms, let it dry for three to five minutes, wash your hands with soap and water, and cover the application area with a t-shirt before any skin-to-skin contact.

The post-application restrictions are the part most clinics gloss over. Per the AndroGel 1.62% prescribing information on DailyMed (NIH-hosted FDA label), you should:

• Wait at least 2 hours (5+ hours preferred) before showering, swimming, or any prolonged water contact
• Cover the application site with clothing whenever it is not freshly washed
• Avoid skin-to-skin contact with women, children, or pets until you have showered
• Not apply to the abdomen, genitals, or any area of damaged or shaved skin (Fortesta is the exception — applied to the inner thighs)
• Rotate application between left shoulder, right shoulder, and the outer upper arms to reduce skin reactions

Timing matters more than men expect. Gels reach peak serum testosterone roughly 6 hours after application, so dosing right before bed defeats the purpose for most morning routines. Most men dose immediately after their morning shower and before any deodorant or sunscreen on the application area.

If you sweat heavily at the gym within 2 hours of applying, you can transfer significant testosterone to clothing and equipment. The same is true if you swim, sit in a sauna, or get rained on. Plan around it.

AndroGel vs Testim vs Fortesta vs Natesto: How Do the Brands Compare?

The four most-prescribed testosterone gels in the U.S. — AndroGel, Testim, Fortesta, and Natesto — all use bioidentical testosterone but differ meaningfully in concentration, application site, dosing schedule, and tolerability. AndroGel is the volume default, Testim has higher application-site irritation, Fortesta uses the inner thigh, and Natesto is the only intranasal option with fertility-preservation data.

Here is the side-by-side:

The key brand-to-brand variable beyond cost is skin tolerability. The original Testim trials reported application-site reactions in roughly 15% of users versus around 6% for AndroGel 1% per the cross-trial data summarized in the PMC review of testosterone gel safety and efficacy. Natesto skips the skin question entirely but introduces nasal congestion (about 3%) and the inconvenience of three-times-daily dosing.

Axiron deserves a footnote. It was the underarm-applied alcohol solution withdrawn from the U.S. market in 2018 over commercial reasons; you may still see it referenced in older content but it is no longer available stateside.

What Is the Right AndroGel Dosage?

Most men start AndroGel 1.62% at 40.5 mg of gel daily (one pump) and titrate up based on labs at week 4 or 6, with typical maintenance doses falling between 40.5 and 81 mg per day. AndroGel 1% generally starts at 50 mg per day (one packet) and ranges 50 to 100 mg. The actual testosterone delivered is roughly 10% of the gel weight, so 50 mg of gel delivers around 5 mg of systemic testosterone.

The titration logic is identical to other TRT modalities: start low, draw labs, adjust. The wrinkle with gels is the timing of that lab draw. Per the Endocrine Society Clinical Practice Guideline on testosterone therapy in men with hypogonadism, gel users should have labs drawn 2 to 8 hours after application — peak window — to assess true serum levels. A trough lab pulled 24 hours after the previous dose will read low and may trigger an unnecessary dose increase.

A common adjustment ladder under provider guidance:

1. Week 0: start at lowest labeled dose (e.g., 40.5 mg AndroGel 1.62%)
2. Week 4–6: morning labs, 2–6 hours post-application
3. If total T < 450 ng/dL: increase by one pump or packet
4. If total T > 1,000 ng/dL: decrease by one pump or packet
5. Recheck at 4–6 weeks after each adjustment

The TRT dosage chart guide covers the dose-response logic across modalities; gel just runs that loop on a daily cadence instead of weekly.

How Long Does Testosterone Gel Take to Work?

Testosterone gel raises serum testosterone within 24 hours of the first dose, reaches steady-state blood levels in 7 to 14 days of consistent daily application, and produces noticeable symptom changes — energy, libido, mood — in 2 to 6 weeks for men who absorb the dose well. Body composition and red blood cell changes follow the standard 3 to 6 month TRT timeline.

The catch is that "for men who absorb the dose well" is not most men. If you are a strong absorber, you will likely feel something different inside the first two weeks. If you are a weak or variable absorber, you may feel almost nothing at week 4, week 8, or even week 12, even with rising doses.

This is why the 4–6 week labs draw is non-negotiable for gel users. Symptom feedback is unreliable for separating "the dose is too low" from "I am not absorbing this gel." Only a peak-window lab can answer that question. If your morning peak total T is still under 400 ng/dL after 6 weeks at the maximum labeled dose, you are most likely a non-responder and the right call is switching modalities — not pushing dose higher.

For a complete view of what symptoms typically improve and on what timeline, see what symptoms indicate TRT is working. The gel-specific addition: track which shoulder you applied to, what time you dosed, and whether you showered within the 2-hour window. Without those data points, you cannot tell absorption variance from dose-response variance.

What Are the Side Effects of Testosterone Gel?

Testosterone gel side effects fall into three buckets: skin reactions at the application site (6–15% of users depending on brand), systemic side effects shared with all TRT routes (acne, hematocrit elevation, sleep apnea, mood changes, possible fertility suppression), and the modality-specific transfer risk to family members carrying an FDA black-box warning. Most are manageable with provider oversight; transfer risk requires daily behavioral change.

Skin reactions are the most common gel-specific complaint. They show up as redness, itching, dryness, or small papules at the application site — most often on the deltoids. Application-site irritation rates per labeling and trial data:

• AndroGel 1%: ~6% of users
• AndroGel 1.62%: ~5%
• Testim: ~15%
• Fortesta: ~12% (inner-thigh skin is more reactive)
• Natesto: ~3% (nasal congestion, nosebleeds, parosmia)

Beyond the skin, gels share the standard TRT side-effect profile detailed in our side effects of TRT guide. Gel users can run into:

• Elevated hematocrit: typically less than weekly injections (which produce sharper peaks), but still possible
• Acne and oily skin: often within the first 4–8 weeks
• Estradiol rise: different daily aromatization profile than weekly peaks; some men do better, others worse
• Sleep apnea worsening: especially in men with pre-existing OSA
• Fertility suppression: all TRT suppresses LH and FSH; topical is no exception, with the partial exception of Natesto covered later

Two side-effect patterns are honest red flags for switching off gel: a hematocrit climbing past 52% by month 3, or persistent nipple sensitivity that does not respond to lifestyle changes. Both are easier to manage on injections, where dose comes down quickly, than on a topical you have to keep applying.

What Is the Transfer Risk to Family Members?

Testosterone gel carries an FDA black-box warning for secondary exposure: any unwashed gel that transfers from your skin to a partner, child, or pet by contact can produce androgenic effects in them, including premature puberty, growth of pubic hair, enlarged genitalia, advanced bone age, and aggression in children, and acne, voice changes, and unwanted hair growth in women. The risk is real, documented in case reports, and the reason post-application restrictions exist.

The FDA mandated the boxed warning for AndroGel and Testim after multiple pediatric exposure cases were documented. Per the PubMed report on the FDA boxed warning for pediatric testosterone gel exposure, exposure pathways include direct skin-to-skin contact within the 2-hour absorption window, transfer via clothing that touched ungelled skin, transfer through shared bedding, and transfer to objects (steering wheels, towels) that another household member then touches.

What this looks like in practice:

• Children: premature puberty, enlarged genitalia, pubic/axillary hair, advanced bone age, behavior changes. In documented cases these reversed after exposure stopped, but advanced bone age is not always fully reversible.
• Women partners: acne, hirsutism, deepening voice, menstrual irregularities, virilization. Pregnant women are at particular risk because testosterone exposure can affect fetal development.
• Pets: less studied, but androgenic effects have been reported in pets that slept on contaminated bedding.

The mitigation is the daily behavior pattern detailed earlier — apply, dry 5 minutes, wash hands, cover with clothing, no skin-to-skin contact within 2 hours, shower before close contact with kids. Contaminated clothing should be washed separately. This is the part of gel TRT no clinic brochure spells out as a daily routine.

If you have small children sleeping in your bed, this risk pattern is reason enough to consider injections instead. The risk is not zero with perfect technique; it is meaningfully lower with a different modality.

Why Are Some Men "Non-Responders" to Testosterone Gel?

Roughly 30% to 50% of men on standard testosterone gel doses fail to reach therapeutic serum levels — the so-called "non-responders" — because transdermal absorption varies dramatically between individuals based on skin thickness, body fat percentage, sweat volume, hydration, application technique, and 30+ patient-specific variables that no clinic visit can predict in advance. Only labs at 4 to 6 weeks confirm whether you absorb the gel.

This is the most under-discussed reality of gel TRT. The published rate is documented in the PMC review on safety and efficacy of testosterone gel and reproduced in multiple subsequent absorption studies. Men with thicker stratum corneum, more body fat, higher daily sweat output, or simply unfavorable skin lipid composition absorb noticeably less of the same applied dose.

Variables documented to affect gel absorption:

• Application site: deltoid > outer arm > inner thigh > abdomen (Fortesta is dosed for thighs specifically)
• Skin temperature and sweat: higher sweat = more washoff
• Recent shower or moisturizer: strips the lipid layer, reduces absorption
• Sun exposure on the site: UV damage changes absorption
• Body fat percentage: higher fat = less efficient absorption per kg
• Age and skin thinning: older skin absorbs differently
• Hydration status: dehydrated skin holds gel longer

The clinical danger of non-response is not that the gel "does not work" — it is that men spend 8 to 12 weeks at a subtherapeutic dose, attributing the lack of symptom improvement to "TRT just takes time," before someone catches the actual problem in a peak-window lab. Months of subtherapeutic treatment is months of unaddressed hypogonadal symptoms.

The right response is structured. If your peak total T is below 450 ng/dL after 6 weeks at a max-label dose, the next step is typically a switch to injections — not a continued dose increase or a longer wait. The PMC comparison of testosterone gels, injections, and pellets reports that injection switchers commonly see immediate symptom resolution within the first week of cypionate dosing.

Testosterone Gel vs Injections: Which Is Better?

Testosterone gel and weekly testosterone cypionate injections are both effective TRT routes for men who absorb gel well, but they trade off in opposite directions. Gels win on convenience for needle-averse men and produce more stable daily blood levels. Injections win on cost (often 5x cheaper), absorption reliability, fertility-preservation flexibility (with HCG), and the ability to course-correct quickly. For most men entering TRT, injections are the safer default.

The honest side-by-side:

A few notes:

The "no needles" pro is real, the "more stable levels" pro is theoretical. Per the cross-modal pharmacokinetic data, gels deliver smoother levels in trial averages but messier levels in individual real-world use because of all the absorption variables above. Injections have a predictable shape; gels have an "it depends" shape.

The cost gap is huge without insurance. Cypionate vials are generic and run $40 to $150 a month. Branded gels run $300 to $600 a month. Even compounded gels, while cheaper, do not match generic cypionate. Our TRT cost breakdown covers the math across all routes.

For fertility-conscious men, the picture is more nuanced. Standard gels suppress the HPG axis the same way injections do. Natesto is the exception, covered below. With injections, you can pair HCG with TRT to maintain testicular function. With most gels, you can do the same — but Natesto specifically may need less of that workaround.

For men who hate needles, travel constantly, or struggle with weekly self-injection adherence, gel is a real option. For everyone else, injections offer better economics and faster troubleshooting.

How Much Does Testosterone Gel Cost?

Testosterone gel costs $300 to $600 per month at retail cash prices for branded products like AndroGel and Testim, $40 to $80 per month for compounded testosterone cream from a compounding pharmacy, and $0 to $80 per month with Tier 2 or Tier 3 insurance coverage of the branded product. Compare that to $40 to $150 per month for generic injectable testosterone cypionate, which most insurance plans cover at the lowest tier.

Cash pricing as of 2026, per GoodRx and major retail pharmacy data:

A few angles most clinic pages skip:

The annual math hurts. $500 per month for branded AndroGel is $6,000 per year. Over 5 years on TRT, that is $30,000. Most men running cypionate at $80 per month spend $4,800 over the same period — a $25,000 difference for the same therapeutic outcome.

Insurance coverage is real but not universal. Major commercial plans typically cover AndroGel and Testim with a prior authorization documenting two morning total T readings under 300 ng/dL and a confirmed hypogonadism diagnosis. Medicare Part D covers branded gels variably. Without coverage, the cash price is brutal.

Compounded cream is dramatically cheaper but unregulated. A compounded 200 mg/mL testosterone cream from a reputable compounding pharmacy can run $40 to $80 per month — roughly the same as cypionate. The catch is FDA oversight: compounded products are not FDA-approved, concentrations can vary batch-to-batch, and quality control depends entirely on the pharmacy. Use a reputable USP 795-compliant pharmacy if you go this route.

Compounded Testosterone Cream vs Branded Gel: What Is the Difference?

Branded testosterone gels (AndroGel, Testim, Fortesta, Natesto) are FDA-approved with established dose precision, batch consistency, and safety data. Compounded testosterone creams are prepared by individual compounding pharmacies under prescription, are not FDA-approved, can be dosed flexibly (e.g., 200 mg/mL custom strengths), but vary in quality between pharmacies and lack the same regulatory oversight. Both deliver the same active molecule.

The key tradeoffs:

Branded gels: - FDA-approved, with phase 3 efficacy and safety data - Identical dose in every pump or packet - Black-box warning required (transfer risk) - Fixed concentrations (1%, 1.62%, 2%) limit dose flexibility - Insurance-coverable (with prior authorization) - Cost $300–$600/mo cash

Compounded creams: - Not FDA-approved (compounded under USP 795/797 standards in most states) - Concentration set by prescriber (often 100, 150, 200 mg/mL) - More dose flexibility — easier to start at 25 mg/day or 75 mg/day - Quality varies pharmacy-to-pharmacy - Rarely covered by insurance - Cost $40–$80/mo cash

"Bioidentical" is a marketing term, not a regulatory designation. Both branded and compounded products use bioidentical (chemically identical to endogenous) testosterone. The difference is oversight, not molecule.

When compounded makes sense: cost-sensitive men without insurance, prescribers who want unusual dose flexibility, men who tried branded and want to test alternative concentrations, men using scrotal application (which is off-label for branded gels and almost always compounded). When branded makes sense: men with good insurance coverage, men starting fresh who want established dose-response data, men who value FDA-overseen QC.

This mirrors the FDA-approved vs compounded distinction in pellet therapy — Testopel is to Biote what AndroGel is to compounded scrotal cream.

Is Scrotal Testosterone Cream Worth Considering?

Scrotal testosterone cream is an off-label compounded application where testosterone cream is applied to scrotal skin instead of the shoulders or arms, and it produces 5 to 8 times the absorption of deltoid application due to the highly vascular, thin scrotal skin. Some clinics — Defy Medical, Marek Health, and similar TRT-direct providers — prescribe it specifically for men who fail to absorb on standard sites. It is not FDA-approved.

The pharmacology is real. Scrotal skin has approximately 8x the testosterone absorption of arm skin, which is why early transdermal patches in the 1980s were specifically scrotal. The original scrotal patch (Testoderm) was discontinued partly because patients found it uncomfortable; modern scrotal cream sidesteps that issue.

The case for scrotal cream: - Very high absorption efficiency — solves the non-responder problem - Lower total daily dose needed - Steady serum levels at lower compound concentrations - Avoids family transfer risk via shoulder contact (though scrotal contact is its own consideration)

The cautions: - Off-label and not FDA-approved - No large-scale trials documenting long-term scrotal application - DHT levels often elevated (scrotal 5-alpha reductase activity is high), which may affect prostate symptoms or hair loss - Application site discomfort is reported by some users - Quality depends entirely on the compounding pharmacy

Honest framing: scrotal cream is a real tool used by experienced TRT providers for selected patients. It is not a default. Consider it only with a provider who has direct experience prescribing and monitoring it, and only after standard-site applications or other modalities have been tried.

Is Natesto the Better Option for Fertility Preservation?

Natesto, the intranasal testosterone gel dosed three times daily, is the only TRT product with published evidence suggesting partial preservation of the hypothalamic-pituitary-gonadal axis at therapeutic doses, meaning men using Natesto retain more LH, FSH, and spermatogenesis than men on weekly cypionate or daily AndroGel. It is the relevant option for fertility-conscious men who want TRT without HCG.

The mechanism is pharmacokinetic, not magical. Per the Natesto pharmacokinetic and fertility data published by Rogol et al., the short-acting intranasal route produces brief testosterone spikes followed by rapid clearance — the HPG axis is not held under continuous suppression the way it is with weekly cypionate or steady-state AndroGel. University of Miami clinical data has reproduced this signal: a meaningful fraction of Natesto users maintain spermatogenesis without adjunct HCG.

Important caveats:

• The fertility data is suggestive, not absolute. Some men still see sperm counts drop on Natesto. The signal is "less suppression than other TRT routes," not "no suppression."
• TID dosing is a real adherence challenge. Three times a day, every day, with the bottle within reach — most men's morning routine handles one dose, not three.
• Nasal congestion and parosmia are reported. A small percentage of users discontinue over nasal side effects.
• Cost is high without insurance. Roughly $550–$700/mo cash.

For men actively trying to conceive within the next 12 months, the standard non-Natesto answer is to pair injections (or another gel) with HCG to preserve fertility, or to consider enclomiphene as an HPG-preserving alternative to TRT entirely. Natesto is a third option for men who specifically want a topical-class product with less HPG suppression and are willing to dose three times daily.

This is not a substitute for fertility planning with a urologist. If conception timing matters, that conversation needs to happen before starting any TRT.

Who Should Choose Testosterone Gel — and Who Should Skip It?

Testosterone gel makes sense for men who absorb topicals well, have insurance coverage that brings cash cost down, value the no-needles routine over weekly self-injection, and do not have small children or partners with daily skin contact. It does not make sense for men who confirmed non-response on labs, lifestyles incompatible with the 2-hour shower window, families with young children, or cost-sensitive patients without insurance.

Choose gel if: - You are clearly needle-averse and would skip injections rather than self-inject - You absorb topicals well (confirm at week 4–6 labs) - You have insurance coverage that brings cash cost under $100/mo - You travel without strict daily windows of post-application skin contact - You have a lifestyle that tolerates a 2-hour shower delay each morning - You do not have skin-contact-heavy daily contact with kids or pets - You specifically want Natesto's HPG-preservation profile (and accept TID dosing)

Skip gel if: - Your week 6 peak total T is under 450 ng/dL on max-label dose (non-responder) - You have small children sleeping in or near your bed - You have a partner concerned about secondary exposure - Your morning routine cannot accommodate a 2-hour shower delay - You do not have insurance and cost-of-treatment is decisive (cypionate is 5x cheaper) - You expect to need frequent dose adjustments in the first year (gels are slower to titrate than injections) - You have a history of significant skin reactions to topicals

For many men starting TRT, gel is the suggested entry point, but injections are the better long-term default for cost, reliability, and adjustability. A reasonable hybrid path is to start gel, run 4–6 weeks of labs, and switch to cypionate if you are in the non-responder bucket. Our how to get on TRT guide covers the broader decision sequence.

How Himcules Helps You Track Gel Therapy

Gel users live with hidden variance. There is no obvious peak/trough cycle to feel — just slow drift in symptoms if absorption is off, plus daily noise from application site, sweat, shower timing, and a dozen other variables. Without structured tracking across the first 4 to 8 weeks, it is genuinely hard to tell whether your dose is wrong, your absorption is off, or you are just having a bad week.

Himcules logs daily dose time, application site, post-application interval before showering, and symptom check-ins on a 1-to-5 scale (energy, libido, mood, sleep) — exactly the data points your provider needs at the 4-week and 12-week labs to decide whether to adjust dose, switch sites, or change modalities. The app keeps this data on-device, so private health information never leaves your phone.

You can download Himcules free on iOS to log gel applications, identify absorption patterns across application sites, and bring real data to your follow-up labs.

Frequently Asked Questions

Q: How long does testosterone gel take to start working? A: Most men feel changes in energy, mood, and libido within 2 to 6 weeks of consistent daily application, with steady-state blood levels reached in 7 to 14 days. Body composition changes follow the standard 3 to 6 month TRT timeline.

Q: Is testosterone gel safer than injections? A: Not categorically. Gel avoids needles and produces smoother daily levels, but it carries an FDA black-box warning for transfer to family members and a 30 to 50% non-responder rate that injections do not have. The right modality depends on your absorption, family situation, and adherence patterns.

Q: Can testosterone gel be transferred to my partner or kids? A: Yes. Skin-to-skin contact within 2 hours of application or contact with contaminated clothing can transfer enough testosterone to cause androgenic effects in women and children. The FDA requires a black-box warning on AndroGel and Testim for this reason.

Q: How much testosterone gel should I apply? A: Standard starting doses are 40.5 mg of AndroGel 1.62% (one pump) or 50 mg of AndroGel 1% (one packet) once daily, with adjustments at 4 to 6 weeks based on labs. Your prescriber will set the actual dose; never adjust without lab data.

Q: Where should you apply testosterone gel? A: Apply to clean, dry shoulders and outer upper arms (or inner thighs for Fortesta), avoiding the abdomen, genitals, and any damaged or shaved skin. Rotate sites between left shoulder, right shoulder, and outer arms to reduce skin reactions.

Q: How much does AndroGel cost without insurance? A: AndroGel 1.62% retails for roughly $480 to $650 per month cash; AndroGel 1% packets run $400 to $550. Compounded testosterone cream costs $40 to $80 per month, and generic injectable cypionate costs $40 to $150 per month.

Q: Why is my testosterone gel not working? A: The most common reason is non-response — 30 to 50% of men do not absorb enough topical testosterone to reach therapeutic levels at standard doses. Confirm with a peak-window lab (2 to 6 hours post-application) at week 4 to 6 before increasing dose; if still subtherapeutic, switching modalities is usually the right move.

Sources

1. AndroGel 1.62% Prescribing Information — DailyMed (NIH-hosted FDA label)
2. Children's exposure to testosterone gel spurs FDA to order boxed label warning — PubMed
3. Endocrine Society Clinical Practice Guideline: Testosterone Therapy in Men With Hypogonadism (Bhasin et al., 2018)
4. Pastuszak et al., "Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen," PMC
5. Wang et al., "Safety and efficacy of testosterone gel in the treatment of male hypogonadism," PMC
6. Rogol et al., "A Phase III, Open-Label, Single-Arm Study Evaluating the Efficacy and Safety of Natesto Nasal Testosterone Gel," PubMed
7. American Urological Association (AUA) Guideline on the Evaluation and Management of Testosterone Deficiency
8. GoodRx — AndroGel pricing and savings information
9. MedlinePlus — Testosterone Topical (.gov consumer health reference)
10. Mayo Clinic — Testosterone (Topical Application Route)

This article is for informational purposes only and is not medical advice. Always consult your healthcare provider about your TRT protocol.